Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
What are the most significant drug interactions you consider when using cenobamate and would you ever consider using cenobamate as monotherapy?
Related Questions
When would you consider using vigabatrin as part of treatment for status epilepticus?
How do you utilize at-home seizure monitoring devices for your patients with epilepsy?
How do you adjust the loading and maintenance doses for Keppra when treating status epilepticus in patients with ESRD, patients on HD, or patients on CVVH?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
When do you need to keep patients on anti-seizure medications when they had an acute symptomatic seizure in the setting of eclampsia, particularly if MgSO4 was given and there was no seizure recurrence?
Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?
When do you consider pacing in arrhythmogenic epilepsy?
When do you consider cannabidiol for treatment of epilepsy?
How does a patient’s BASED score after starting infantile spasms therapy guide your treatment plan?
What recommendations would you make for a patient on long-term phenytoin due to epilepsy with a newly diagnosed breast cancer requiring doxorubicin as part of her chemotherapy?
